Globus Medical, Inc. (GMED)
NYSE: GMED · Real-Time Price · USD
92.46
+2.30 (2.55%)
At close: Jan 14, 2026, 4:00 PM EST
91.71
-0.75 (-0.81%)
After-hours: Jan 14, 2026, 7:22 PM EST
Globus Medical Market Cap
Globus Medical has a market cap or net worth of $12.37 billion as of January 14, 2026. Its market cap has increased by 8.76% in one year.
Market Cap
12.37B
Enterprise Value
12.09B
1-Year Change
8.76%
Ranking
Category
Stock Price
$92.46
Market Cap Chart
Since August 3, 2012, Globus Medical's market cap has increased from $1.22B to $12.37B, an increase of 914.16%. That is a compound annual growth rate of 18.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 14, 2026 | 12.37B | 5.90% |
| Dec 31, 2025 | 11.69B | 3.76% |
| Dec 31, 2024 | 11.26B | 53.38% |
| Dec 29, 2023 | 7.34B | -0.98% |
| Dec 30, 2022 | 7.42B | 1.22% |
| Dec 31, 2021 | 7.33B | 13.84% |
| Dec 31, 2020 | 6.44B | 9.95% |
| Dec 31, 2019 | 5.85B | 37.32% |
| Dec 31, 2018 | 4.26B | 7.60% |
| Dec 29, 2017 | 3.96B | 66.61% |
| Dec 30, 2016 | 2.38B | -10.27% |
| Dec 31, 2015 | 2.65B | 17.98% |
| Dec 31, 2014 | 2.25B | 19.34% |
| Dec 31, 2013 | 1.88B | 96.83% |
| Dec 31, 2012 | 956.00M | -21.65% |
| Aug 3, 2012 | 1.22B | - |
View and export this data all the way back to 2012. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 967.91B |
| Johnson & Johnson | 505.28B |
| AbbVie | 388.90B |
| UnitedHealth Group | 308.45B |
| AstraZeneca | 294.97B |
| Novartis AG | 274.30B |
| Merck & Co. | 271.01B |
| Novo Nordisk | 263.26B |